4 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Points #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Points #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Group #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... AdverseEvents #NEJM ... #NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
point of major or clinically ... Panel A) #EBM #Cardiology ... #IM #REDUAL #Dabigatran ... AtrialFibrillation #NEJM